Shareholders' equity · 2011–2025
Vertex Pharmaceuticals shareholders' equity
$18.7B+13.7% · FY2025
Vertex Pharmaceuticals (VRTX) reported $18.7B in shareholders' equity for fiscal 2025, +13.7% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $18.7B | +13.7% | Open → |
| FY20242024-12-31 | $16.4B | −6.7% | Open → |
| FY20232023-12-31 | $17.6B | +26.4% | Open → |
| FY20222022-12-31 | $13.9B | +37.7% | Open → |
| FY20212021-12-31 | $10.1B | +16.3% | Open → |
| FY20202020-12-31 | $8.7B | +42.8% | Open → |
| FY20192019-12-31 | $6.1B | +37.2% | Open → |
| FY20182018-12-31 | $4.4B | +118.6% | Open → |
| FY20172017-12-31 | $2.0B | +75.4% | Open → |
| FY20162016-12-31 | $1.2B | +23.0% | Open → |
| FY20152015-12-31 | $940M | −12.6% | Open → |
| FY20142014-12-31 | $1.1B | −20.7% | Open → |
| FY20132013-12-31 | $1.4B | +35.8% | Open → |
| FY20122012-12-31 | $999M | +27.0% | Open → |
| FY20112011-12-31 | $787M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +25.4%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Vertex Pharmaceuticals shareholders' equity |url=https://companiesranked.com/en/company/vertex-pharmaceuticals/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Vertex Pharmaceuticals shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/vertex-pharmaceuticals/shareholders-equityBibTeX
@misc{companiesranked-en-company-vertex-pharmaceuticals-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Vertex Pharmaceuticals shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/vertex-pharmaceuticals/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0000875320-26-000259 · August 4, 2026
{{cite web |title=Vertex Pharmaceuticals shareholders' equity — 10-Q (0000875320-26-000259) |url=https://www.sec.gov/Archives/edgar/data/875320/000087532026000259/vrtx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.